| | Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76Edited by Vladimir Skulachev Received 7 August 2008; received in revised form 28 August 2008; accepted 1 September 2008. published online 10 September 2008. Abstract This study was undertaken to characterize the consequences of Ral-interacting protein (RLIP76)-loss with respect to drug resistance, transport, radiation resistance, and alternative transport mechanisms in mouse embryonic fibroblasts (MEFs). MEFs were derived from RLIP76+/+, RLIP76+/− and RLIP76−/− mice. The transport of doxorubicin (DOX), colchicine (COL), leukotriene C4 and dinitrophenyl S-glutathione (DNP-SG) was analyzed in inside-out vesicles (IOVs) prepared from MEFs. We used immuno-titration of transport activity to determine the contribution of RLIP76, MRP1, and p-glycoprotein (Pgp) towards total transport activity. Loss of RLIP76 alleles resulted in significant sensitization to radiation, DOX, cisplatin, and vinorelbine (VRL). In IOVs prepared from MEFs, we observed a stepwise loss of transport activity. Loss of RLIP76 confers sensitivity to xenobiotics and radiation due to the loss of a common transport mechanism for glutathione–electrophile conjugates and xenobiotics. Abbreviations: RLIP76 (RalBP1), Ral-interacting protein, GSH, glutathione, GS-E, glutathione–electrophile conjugates, DNP-SG, dinitrophenyl S-glutathione, COL, colchicine, DOX, doxorubicin, 4HNE, 4-hydroxynonenal, IOVs, inside-out vesicles, LTC4, leukotriene C4, MEFs, mouse embryonic fibroblasts, MRP, multi-drug resistance associated protein, Pgp, p-glycoprotein, VRL, vinorelbine, RLIP76+/+, wild-type, RLIP76+/−, heterozygous, RLIP76−/−, homozygous Department of Molecular Biology and Immunology, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, EAD RM No. 542, Fort Worth, TX 76107-2699, United States Corresponding author. Fax: +817 735 2118.
PII: S0014-5793(08)00734-5 doi:10.1016/j.febslet.2008.09.001 © 2008 Federation of European Biochemical Societies | |
|
|